Dear Doctor Letter (Rote-Hand-Brief) on Tavanic® (levofloxacin) and generic medicinal products: Restriction of indications, new serious adverse reactions and precautions for use
2012.09.03
Active substance: levofloxacin
In agreement with the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), restrictions of indications and the inclusion of new serious adverse reactions as well as corresponding warnings in the product informations have been decided for all medicinal products containing levofloxacin (Tavanic® and generics).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN